Skip to main content

Table 1 Overview on patients' characteristics and treatment

From: First experiences in treatment of low-grade glioma grade I and II with proton therapy

Patient Gender Age Histology Localization Opticpathway glioma CTV [ccm] Beam count Isodose level in scalp [%] Previous therapy Total dose (GyE) Single dose (GyE) Time interval between inital diagnosis and initiation of proton beam therapy [months]
1 male 10 pilocytic astrocytoma WHO °I central no 11 2 10 resection 54 2 45
2 male 38 pilocytic astrocytoma WHO °I central no 35 2 30 resection 54 1,8 20
3 female 12 pilomyxoid astrocytoma WHO °II central yes 48 2 30 chemotherapy 54 1,8 >116
4 male 37 pilocytic astrocytoma WHO °I central no 220 2 30 resection 54 2 44
5 female 17 pilocytic astrocytoma WHO °I central to peripheral no 99 2 70 resection 54 1,8 80
6 male 39 astrocytoma WHO °II central to peripheral no 266 2 70 chemotherapy 54 1,8 69
7 female 12 fibrillary astrocytoma WHO °II central to peripheral no 212 2 90 resection 48,6 1,8 48
8 female 48 astrocytoma WHO °II central to peripheral no 75 1 70 biopsy only 54 2 3
9 female 36 fibrillary astrocytoma WHO °II central to peripheral no 212 2 70 resection 54 1,8 85
10 female 38 astrocytoma WHO °II peripheral no 187 2 70 biopsy only 54 1,8 11
11 female 28 astrocytoma WHO °II central to peripheral no 371 2 70 resection 54 1,8 26
12 male 56 astrocytoma WHO °II central to peripheral no 463 1 70 biopsy only 50,4 1,8 15
13 female 36 oligoastrozytoma WHO °II central to peripheral no 298 2 70 chemotherapy 54 1,8 42
14 male 13 pilocytic astrocytoma WHO °I central yes 204 2 30 chemotherapy 54 1,8 132
15 male 16 pilocytic astrocytoma WHO °I central no 17 2 30 biopsy only 54 1,8 99
16 male 29 pilocytic astrocytoma WHO °I central no 15 2 10 biopsy only 54 2 4
17 male 4 pilocytic astrocytoma WHO °I central no 6 2 30 resection 54 1,8 8
18 male 7 pilocytic astrocytoma WHO °I central yes 19 2 10 chemotherapy 50,4 1,8 33
19 female 43 astrocytoma WHO °II central no 57 2 30 biopsy only 52,2 1,8 4